Name | Methylergometrine maleate,[8β(S)]-9,10-Didehydro-N-[1-(hydroxymethyl)propyl]-6-methylergoline-8-carboxamidemaleate |
---|---|
Synonyms |
Methylergobasine
D-Lysergic acid-(+)-butanolamide-(2) (8β)-N-[(2S)-1-Hydroxybutan-2-yl]-6-methyl-9,10-didehydroergoline-8-carboxamide Methylergometrin [8b(S)]-9,10-Didehydro-N-[1-(hydroxymethyl)propyl]-6-methylergoline-8-carboxamide methylergometrine N-[a-(Hydroxymethyl)propyl]-D-Iysergamide Methylergobrevin EINECS 204-027-0 (8β)-N-[(2S)-1-Hydroxy-2-butanyl]-6-methyl-9,10-didehydroergoline-8-carboxamide D-Lysergic Acid (+)-Butanolamide-(2) (8β)-N-[(1S)-1-(hydroxymethyl)propyl]-6-methyl-9,10-didehydroergoline-8-carboxamide Prestwick_727 Methylergonovine Ergoline-8-carboxamide, 9,10-didehydro-N-[(1S)-1-(hydroxymethyl)propyl]-6-methyl-, (8β)- |
Description | Methylergometrine (Methylergonovine) is an orally active 5-HT2B ligand agonist. Methylergometrine can be used as oxytocin and has protective effect on postpartum hemorrhage[1][2][3]. |
---|---|
Related Catalog | |
Target |
5-HT2B Receptor |
References |
Density | 1.3±0.1 g/cm3 |
---|---|
Boiling Point | 638.4±55.0 °C at 760 mmHg |
Melting Point | 172ºC |
Molecular Formula | C20H25N3O2 |
Molecular Weight | 339.431 |
Flash Point | 339.9±31.5 °C |
Exact Mass | 339.194672 |
PSA | 68.36000 |
LogP | 1.67 |
Vapour Pressure | 0.0±2.0 mmHg at 25°C |
Index of Refraction | 1.665 |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
~% 113-42-8 |
Literature: Collection of Czechoslovak Chemical Communications, , vol. 22, p. 1866,1868,1871 Helvetica Chimica Acta, , vol. 26, p. 944,947 Hoppe-Seyler's Zeitschrift fuer Physiologische Chemie, , vol. 251, p. 155,160 Collection of Czechoslovak Chemical Communications, , vol. 21, p. 382,386 |
~% 113-42-8 |
Literature: Collection of Czechoslovak Chemical Communications, , vol. 22, p. 1866,1868,1871 |
~% 113-42-8
Detail
|
Literature: Collection of Czechoslovak Chemical Communications, , vol. 22, p. 1866,1868,1871 |
Precursor 3 | |
---|---|
DownStream 0 |